Labiotech article: How clinical trials benefit from decentralized solutions: A Nordic case studyPublished: September 21, 2022
Another milestone reached for AlzeCure’s Phase II clinical trial in neuropathic pain with non-opioid ACD440Published: June 22, 2022
LINK Medical, the Northern European CRO has raised capital to fund further growthPublished: May 2, 2022
Closing the gap between developers and users results in a unique eTMF solutionPublished: April 20, 2022
Labiotech article, on The Trial of the Future: Using Digital Technologies to Enable Decentralized TrialsPublished: March 22, 2022
Full-service CRO LINK Medical and Viedoc™ sign a new partnership agreementPublished: February 15, 2022
